本页面由Tiger Trade Technology Pte. Ltd.提供服务

Palvella Therapeutics

145.75
+3.712.61%
盘后145.750.00000.00%19:30 EDT
成交量:31.55万
成交额:4,469.90万
市值:21.00亿
市盈率:-29.76
高:146.69
开:141.78
低:136.06
收:142.04
52周最高:161.38
52周最低:49.13
股本:1,440.84万
流通股本:839.81万
量比:1.71
换手率:3.76%
股息:- -
股息率:- -
每股收益(TTM):-4.8978
每股收益(LYR):-3.7076
净资产收益率:-46.63%
总资产收益率:-22.05%
市净率:9.68
市盈率(LYR):-39.31

数据加载中...

2026/08/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/14

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/14

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/10

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/08/05

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/08/04

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/08/04

重要事件披露

Form 8-K - Current report
2026/08/03

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/07/30

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/07/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/07/14

重要事件披露

Form 8-K - Current report
2026/06/30

重要事件披露

Form 8-K - Current report
2026/06/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/16

重要事件披露

Form 8-K - Current report
2026/05/20

重要事件披露

Form 8-K - Current report
2026/05/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/15

重要事件披露

Form 8-K - Current report
2026/05/13

重要事件披露

Form 8-K - Current report
2026/05/07

重要事件披露

Form 8-K - Current report
2026/05/07

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]